Official Study Title: Safety and Tollerability of Isradipine (A Potential Neuroprotective Agent) in Patients with Parkinson’s Disease
The objective of this study is to establish the safety and tolerability of Isradipine in patients with normal blood pressure. This study is conducted in preparation to an NIH submission on the efficacy of this agent as a neuroprotection in Parkinson’s disease.
http://www.pdtrials.org/front/trial_...p?trial_id=177
http://www.parkinsons.northwestern.edu/research.html
For more information, please call Research Coordinators at 312/503-2593 or 312/503-5645 (at the Northwestern University Parkinson's Disease and Movement Disorders Center)